Keywords: Salix Pharma, Alfa Wassermann, Rifaximin, Gastrointestinal, Respiratory indicatiions

Salix and Alfa Wassermann expand rifaximin accord

Article | 10 August 2012

Print This

USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy’s Alfa Wassermann have entered into an exclusive agreement by which Salix ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in